Discover 1,670 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,670
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: New York NY, Hackensack NJ, New Haven CT, Baltimore MD,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase 3, Recruiting
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
for
Breast Cancer
Location: New York NY, Montvale NJ
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 18+
Code: NCT05130801
Phase 1, Phase 2, Recruiting
Clinical Trial of Approaches to Prostate Cancer Surgery
for
Prostate Cancer
Location: New York NY, Hackensack NJ, Flushing NY, Baltimore MD,
Sponsor: Weill Medical College of Cornell University
Sex: Male
Age: 40 - 70+
Code: NCT05155501
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: New York NY, Paramus NJ, West Reading PA, Hershey PA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase 3, Recruiting
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: New York NY, Fort Lee NJ, Urbana IL, Birmingham AL,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04640532
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: New York NY, Hackensack NJ, Stony Brook NY, York PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
for
Higher-risk Myelodysplastic Syndrome
Location: New York NY, Hackensack NJ, The Bronx NY, Baltimore MD,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06641414
Phase 3, Recruiting
A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness
for
Brain Injury
Location: Edison NJ
Sponsor: International Brain Research Foundation
Sex: All
Age: 18 - 65
Code: NCT02696512
Phase 1, Phase 2, Recruiting
International Registry for Severe Chronic Neutropenia
for
Neutropenia
Location: Paterson NJ, Worcester MA, Boston MA, Toronto,
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 0+
Code: NCT00004342
Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for
Cervical Squamous Cell Carcinoma,
Location: Hackensack NJ, New Haven CT, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07169734
Phase 1, Phase 2, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: New York NY, Palisades Park NJ, Greenwich CT,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase 3, Recruiting
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
for
Small Cell Lung Cancer (SCLC ),
Location: New York NY, Hackensack NJ, Nashville TN, St Louis MO,
Sponsor: Moonlight Bio, Inc
Sex: All
Age: 18+
Code: NCT07488923
Phase 1, Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for
Refractory Angina
Location: New York NY, Hackensack NJ, Roslyn NY, New Haven CT,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT05102019
Recruiting
OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression
for
Post Partum Depression
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: Female
Age: 18+
Code: NCT06991166
Recruiting
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
for
Solid Tumor
Location: New York NY, Hackensack NJ, Newark DE, Providence RI,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT05584670
Phase 1, Phase 2, Recruiting
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
for
Open Surgery, Lymphedema, Free Tissue Transfer, Microsurgery,
Location: New York NY, Hackensack NJ, New Haven CT, Buffalo NY,
Sponsor: MMI (Medical Microinstruments, Inc.)
Sex: All
Age: 22+
Code: NCT06725030
Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: New York NY, Hackensack NJ, Hershey PA, Baltimore MD,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Location: New York NY, Hackensack NJ, The Bronx NY, Mineola NY,
Sponsor: Taiho Oncology, Inc.
Sex: All
Age: 18+
Code: NCT04256317
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, Hackensack NJ, Boston MA, Buffalo NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06121843
Phase 1, Recruiting
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Manahawkin NJ, Fairfax VA, Pittsburgh PA, Cleveland OH,